Canada [change]  |  Francais
    Healthcare Professionals > CE Essentials > CE Essentials Print  
s
 Healthcare Professionals
 newpharmacist
 iPharmacist
 CE Essentials
 Apo-Clozapine
 Practice Tools
 DISpedia
 Student Programs
 Pharmacy Links
 




These programs are available by contacting your Apotex Representative.

Essentials 2008

Hypertension
Drawing on recommendations from the Canadian Hypertension Education Program, CE Essentials: Hypertension provides pharmacists with a concise overview of the diagnosis, management and monitoring of this important vascular disorder.


Coming Soon...

Osteoporosis
CE Essentials: Osteoporosis reviews the diagnosis, management and monitoring of this under-recognized condition that affects 1 in 4 women and 1 in 8 men over the age of 50 years.

Osteoarthritis
Osteoarthritis is the most common form of arthritis, affecting an estimated 1 in 10 Canadians. Using the latest clinical practice guidelines, CE Essentials: Osteoarthritis provides pharmacists with an up-to-date summary of its treatment.

Asthma
CE Essential: Asthma gives pharmacists a timely overview of asthma treatment, based on the recently-released Canadian clinical practice guidelines. Highlights include updated asthma control criteria and considerations in pediatric patients.

 

Essentials 2007

Dyslipidemia
CE Essentials: Dyslipidemia provides pharmacists with a timely update on the management of dyslipidemia, drawing on recommendations from the 2006 Canadian clinical practice guidelines.

Chronic Obstructive Pulmonary Disease
CE Essentials: COPD provides a concise yet comprehensive overview of chronic obstructive pulmonary disease, a debilitating condition that is currently the fourth leading cause of death in men and the fifth in women.

Schizophrenia
Schizophrenia affects speech, emotions, behaviour and thought. It is often mistakenly confused with multiple personality disorder. CE Essentials: Schizophrenia will help you understand this complex illness, affecting approximately 1% of the world's population.


Essentials 2006

Heart Failure
Drawing on recommendations from the 2006 Canadian guidelines, CE Essentials: Heart Failure provides an overview of heart failure management, with emphasis on the most prominent type, systolic dysfunction heart failure.

Type 1 Diabetes
The ‘ins and outs' of insulin dosing are presented in CE Essentials: Type 1 Diabetes. Learn more about the role that pharmacists can play in helping patients (including children and adolescents) manage this challenging lifelong condition.

Stroke
Primary and secondary prevention of ischemic stroke are reviewed in CE Essentials: Stroke, including recommendations for risk factor management. This module also discusses current evidence regarding the use of antiplatelet therapies and warfarin in stroke prevention. 

Angina
CE Essentials: Angina reviews current guidelines for managing angina pectoris, with particular emphasis on chronic stable angina. Topics include acute and chronic symptom management, prevention of disease progression and useful monitoring parameters for pharmacists.